Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:31:30.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T18:59:17.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T14:58:53.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Version 3.4.2 (2026-02-03) adds Contacts/Locations and Study Status to the record history. The prior revision 3.4.0 (2025-10-06) was removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:42:36.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a glossary toggle and a color-coded change legend; updated revision to v3.4.0 and removed the No FEAR Act Data and the v3.3.4 entry.
    Difference
    0.5%
    Check dated 2026-01-27T22:37:46.000Z thumbnail image
  8. Check
    118 days ago
    Change Detected
    Summary
    Footer metadata changes: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T01:13:16.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.